EUCTR2005-003770-23-BE进行中（未招募）不适用
Randomized, two arm, controlled study to compare the efficacy oforal ibandronate treatment versus intravenous zoledronate in patientswith symptomatic Multiple Myeloma
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 424
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with multiple myeloma & confirmation of bone lesions
- •Age > 18 years
- •Patient’s written informed consent
- •WHO performance status 0-2
- •Life expectancy of ? 6 months
- •Adequate renal function (defined by a creatinine clearance >60 ml/min)
- •No history of brain metastases
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Any circumstance liable to compromise follow-up and compliance
- •Pregnant or lactating period
- •Participation in a clinical trial with any investigational drug within 4 weeks preceding the first dose of the study drug
- •History of other concomitant cancer in evolution
- •Prior bisphosphonate treatment with the exception of bisphosphonate treatment for hypercalcemia and osteoporosis
- •Pre-scheduled radiotherapy that would fall within the study period
研究者
相似试验
进行中（未招募）
不适用
Randomized, two arm, controlled study to compare the efficacy oforal ibandronate treatment versus intravenous zoledronate in patientswith symptomatic Multiple MyelomaMultiple MyelomaEUCTR2005-003770-23-SIF. Hoffmann-La Roche Ltd424
进行中（未招募）
1 期
Randomized, two arm, controlled study to compare the efficacy oforal ibandronate treatment versus intravenous zoledronate in patientswith symptomatic Multiple MyelomaMultiple MyelomaEUCTR2005-003770-23-GBF. Hoffmann-La Roche Ltd424
进行中（未招募）
不适用
Randomized, two arm, controlled study to compare the efficacy oforal ibandronate treatment versus intravenous zoledronate in patientswith symptomatic Multiple MyelomaMultiple MyelomaEUCTR2005-003770-23-EEF. Hoffmann-La Roche Ltd424
进行中（未招募）
1 期
Randomized, two arm, controlled study to compare the efficacy oforal ibandronate treatment versus intravenous zoledronate in patientswith symptomatic Multiple MyelomaMultiple MyelomaEUCTR2005-003770-23-SKF. Hoffmann-La Roche Ltd424
进行中（未招募）
不适用
Randomized, two arm, controlled study to compare the efficacy oforal ibandronate treatment versus intravenous zoledronate in patientswith symptomatic Multiple MyelomaMultiple MyelomaEUCTR2005-003770-23-HUF. Hoffmann-La Roche Ltd424